Mobia Medical went public but saw its shares drop over 20% on the first day, reflecting investor caution. The company’s Vivistim Paired VNS system targets the stroke recovery market, with revenues expected to double to $32 million by 2025. However, operating losses are also projected to nearly double, raising concerns about profitability. Despite a strong cash position and sales growth, high costs and lack of operating leverage keep investors hesitant, with some waiting for clearer signs of sustained commercial success before investing.
Halper Sadeh LLC is investigating whether the sales and merger deals involving AstroNova, Simulations Plus, and Olin Corporation provide fair treatment to their shareholders. The firm suspects insiders may gain financial benefits not available to ord...
Halper Sadeh LLC is investigating whether shareholders of Apogee Therapeutics, Open Lending, Huntsman, and Avanos Medical are receiving fair deals in their companies' recent sales. The law firm suspects insiders may gain financial benefits not availa...
CEA Industries and YZi Labs have reached a cooperation agreement to strengthen governance at CEA Industries, which manages the world's largest corporate treasury of BNB. The agreement includes appointing three new board members with digital asset exp...
Rise Nano Optics has formed a strategic partnership with SportifEye Optics to manufacture and distribute its patented SpectraGuard lens technology in the United States. SpectraGuard lenses offer advanced eye protection by filtering 100% of UV light a...
B2Gold is seen as a compelling investment opportunity because current operational slowdowns and risks related to Mali are already factored into its stock price. The company's high all-in sustaining costs in 2026 are temporary, driven by deferred stri...
